Skip to content

Clinical trials

Phase 1/2 Squamous Cell Carcinoma of Head and Neck trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Squamous Cell Carcinoma of Head and Neck Phase: Phase 1/2 Country / region: Netherlands Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20161
20171
20181
20191
20211
20221
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting3
Terminated2
Unknown status2
Active, not recruiting1
Completed1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merus B.V.2
University Medical Center Groningen2
Amgen1
Daiichi Sankyo1
Eli Lilly and Company1
Hookipa Biotech GmbH1
Novartis Pharmaceuticals1
Radboud University Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Squamous Cell Carcinoma of Head and Neck10
Colorectal Neoplasms3
Head and Neck Neoplasms3
Uterine Cervical Neoplasms3
Endometrial Neoplasms2
Hereditary Sensory and Autonomic Neuropathies2
Ovarian Neoplasms2
Stomach Neoplasms2
Adenocarcinoma of Lung1
Biliary Tract Neoplasms1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.